Free Trial

Novacyt (NCYT) Competitors

Novacyt logo
GBX 38.29 -1.81 (-4.51%)
As of 04/25/2025 11:08 AM Eastern

NCYT vs. EKF, IUG, CREO, POLX, IHC, AVO, RUA, MHC, SUN, and BELL

Should you be buying Novacyt stock or one of its competitors? The main competitors of Novacyt include EKF Diagnostics (EKF), Intelligent Ultrasound Group (IUG), Creo Medical Group (CREO), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), MyHealthChecked (MHC), Surgical Innovations Group (SUN), and Belluscura (BELL). These companies are all part of the "medical devices" industry.

Novacyt vs.

EKF Diagnostics (LON:EKF) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, community ranking, media sentiment and dividends.

70.3% of EKF Diagnostics shares are held by institutional investors. Comparatively, 0.1% of Novacyt shares are held by institutional investors. 5.2% of EKF Diagnostics shares are held by company insiders. Comparatively, 3.1% of Novacyt shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

EKF Diagnostics has higher revenue and earnings than Novacyt. Novacyt is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EKF Diagnostics£49.91M1.87£4.68M£1.0719.54
Novacyt£18.12M1.46-£36.80M-£54.44-0.70

EKF Diagnostics has a net margin of 9.37% compared to Novacyt's net margin of -203.06%. EKF Diagnostics' return on equity of 7.03% beat Novacyt's return on equity.

Company Net Margins Return on Equity Return on Assets
EKF Diagnostics9.37% 7.03% 5.27%
Novacyt -203.06%-47.73%-27.98%

EKF Diagnostics received 291 more outperform votes than Novacyt when rated by MarketBeat users. Likewise, 76.76% of users gave EKF Diagnostics an outperform vote while only 58.06% of users gave Novacyt an outperform vote.

CompanyUnderperformOutperform
EKF DiagnosticsOutperform Votes
327
76.76%
Underperform Votes
99
23.24%
NovacytOutperform Votes
36
58.06%
Underperform Votes
26
41.94%

EKF Diagnostics has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, Novacyt has a beta of -1.86, indicating that its stock price is 286% less volatile than the S&P 500.

In the previous week, EKF Diagnostics' average media sentiment score of 0.00 equaled Novacyt'saverage media sentiment score.

Company Overall Sentiment
EKF Diagnostics Neutral
Novacyt Neutral

Summary

EKF Diagnostics beats Novacyt on 13 of the 13 factors compared between the two stocks.

Get Novacyt News Delivered to You Automatically

Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter.

NCYT vs. The Competition

MetricNovacytMedical Devices IndustryMedical SectorLON Exchange
Market Cap£26.46M£3.16B£5.47B£2.55B
Dividend YieldN/A2.45%5.43%4.80%
P/E Ratio-0.7066.2822.39132.49
Price / Sales1.46117.42391.41241,309.84
Price / Cash0.5815.9938.1828.31
Price / Book0.383.666.684.53
Net Income-£36.80M£126.02M£3.22B£5.86B
7 Day Performance-6.60%0.21%6.24%8.61%
1 Month Performance-11.53%-7.84%-2.81%6.37%
1 Year Performance-44.21%-14.94%16.47%103.30%

Novacyt Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NCYT
Novacyt
N/AGBX 38.29
-4.5%
N/A-44.5%£26.46M£18.12M-0.70120
EKF
EKF Diagnostics
N/AGBX 21.40
-0.7%
N/A-24.5%£95.12M£49.91M19.92356
IUG
Intelligent Ultrasound Group
N/AN/AN/AN/A£42.76M£6.57M-18.9165
CREO
Creo Medical Group
N/AGBX 9.59
-0.4%
N/A-73.3%£38.76M£33.87M-1.52279
POLX
Polarean Imaging
N/AGBX 1.08
+4.9%
N/A-71.8%£15.78M£5.21M-0.2828Gap Down
High Trading Volume
IHC
Inspiration Healthcare Group
N/AGBX 16.65
+0.9%
N/A-46.4%£14.42M£42.87M-1.14224
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
RUA
RUA Life Sciences
N/AGBX 12.79
+11.2%
N/A+10.7%£7.94M£4.05M-2.9848
MHC
MyHealthChecked
N/AGBX 14.40
+2.9%
N/A+40.0%£7.49M£9.43M-7.1816
SUN
Surgical Innovations Group
N/AGBX 0.51
-2.3%
N/A+5.6%£4.79M£12.54M-21.1180News Coverage
Gap Down
BELL
Belluscura
N/AGBX 0.65
+0.6%
N/A-91.0%£1.65M£2.87M-0.0724

Related Companies and Tools


This page (LON:NCYT) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners